VAIL SCIENTIFIC:

Revolutionizing Sepsis Detection

Our VISION

Our vision is a world where any patient can be quickly and accurately screened for sepsis at point-of-care.

With every hour of delay, sepsis patients’ mortality increases by 8%. As many as 80% of sepsis deaths could be avoided with rapid diagnosis and treatment.

Rapid diagnosis and treatment of sepsis is critical. Yet, there is no accurate screening technology or protocol for early detection of sepsis.

Vail Scientific is empowering healthcare providers with cutting-edge solutions for early sepsis detection, enabling enhanced patient outcomes and reduced mortality rates.

our solution

Our Story

Its time for rapid change.

Vail Scientific was established by four founders with over 80 years of combined industry experience. We are inventors, named on over 50 patents. We are authors, publishing work on over 20 peer-reviewed scientific publications. Our team has a proven track-record of success, commercializing over a dozen new industry products. Since 2019, we have been been dedicated to reducing sepsis mortality, and enabling hospitals to save lives with shortening the time from triage to treatment.

We are a proud member of Medical Alley and partner with Minnetronix Medical, one the most trusted medical device development resources in the world. We are guided by leaders in sepsis healthcare, surgeons, nurses, emergency care providers, and experts who have spent their careers in a daily fight. Patients are still dying today from the same mistakes of decades ago. We are passionately driven to save lives, and there is no time to waste.

Vail Scientific partners with Minnetronix Medical

Our Focus

Pushing boundaries. Improving patient outcomes and combating sepsis mortality rates.

Our Mission

Saving lives through early detection of sepsis.

Our Values

Integrity, Innovation, Collaboration: upholding these values to enhance patient care and combat sepsis mortality.

leadership

Tom Burke, MBA

Chief Executive Officer, Chairman of Board

30+ years of experience as a forward-thinking, global strategic leader in the pharmaceutical industry. Diverse management experience leading organizations from $1M to $600M+. CEO of several healthcare start-up organizations. Past COO – Upsher-Smith Laboratories.

Carter Anderson, MS

Chief Technology Officer, Board Member

30+ years of experience in the medical device and pharmaceutical industries, with 28 patents, 10 scientific journal publications. Co-founder and CTO – Verde Technologies, Founder past CTO – Travanti Pharma Inc. Co-founder and Director of R&D – Diametrics Medical, Research Scientist – Medtronic.

Curtis Carlson

Board Member

25+ years of experience as an accomplished business leader and sales & marketing executive focused on all aspects of medical devices. Proven success in distribution management, marketing, contracting, reimbursement, business development, and fundraising, resulting in product launches into Surgical, Outpatient, Physical Med & Rehab.

Mike Nathan, MBA

Board Member

Co-Founder, CEO of Mendota Health. Mike is also an active founder at Big Stone Capital Group, TurnSignl, and FritzFinn, while serving as board member for several start-up companies. He is founder, investor, or advisor to over 12 start-up companies. He attended St. John’s University before serving 4.5 years in the United States Navy.

Josh Robinson

Board Member

20+ years of experience enabling sustainable business growth with a relentless pursuit of continuous improvement. Josh is Exit 156 Capital Managing Partner. He has a bachelor’s in Finance from Saint John’s University and advanced degrees and certifications from the University of South Dakota and MIT. He has held senior executive roles in both Finance and IT in organizations of $50M to $7B.

Robert Arnold, MBA

Advisor

30+ years general management, business development, licensing, marketing, sales and clinical research experience in the medical device and pharmaceutical industries. Travanti, VP & General Manager–Medical, VP Sales, Marketing & Business Development; The Tapemark Company, VP Sales & Marketing; CIMA Labs, Sr VP Business Development.

Guido Baechler

Advisor

30+ years experience in the diagnostic, medical device, and life science sectors. Currently CEO of Mainz BioMed, a premier
colorectal cancer diagnostic firm. Previously held CEO positions at Summerbio and Singulex. Prior to these ventures, dedicated close to 20 years to Roche Diagnostics.

Medical and Clinical Advisors

Karin Molander, MD

Past Chair, Board of Directors Sepsis Alliance

Greg Beilman, MD

Critical Care Surgeon Minneapolis, MN

Casey Clements, MD, PHD

Emergency Medicine Rochester, MN

Kendal Farrar, MD

Emergency Medicine Minneapolis, MN

Glen Hansen, PHD

Medical Microbiology/Molecular Diagnostics Minneapolis, MN

Michael Puskarich MD, MS

Emergency Medicine Minneapolis, MN

Michael D. Zwank, MD

Emergency Medicine St. Paul, MN

Rapid Sepsis Detection
Starts Now

let’s GO